ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 104 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $10,000 | -23.1% | 7,403 | 0.0% | 0.00% | – |
Q4 2021 | $13,000 | -18.8% | 7,403 | 0.0% | 0.00% | -100.0% |
Q3 2021 | $16,000 | -38.5% | 7,403 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $26,000 | -64.4% | 7,403 | 0.0% | 0.00% | -66.7% |
Q1 2021 | $73,000 | -8.8% | 7,403 | 0.0% | 0.00% | -25.0% |
Q4 2020 | $80,000 | +5.3% | 7,403 | 0.0% | 0.00% | +33.3% |
Q3 2020 | $76,000 | -43.7% | 7,403 | +14.8% | 0.00% | -50.0% |
Q2 2020 | $135,000 | +150.0% | 6,451 | +17.1% | 0.01% | +100.0% |
Q1 2020 | $54,000 | +5.9% | 5,510 | +25.3% | 0.00% | +50.0% |
Q4 2019 | $51,000 | +112.5% | 4,398 | 0.0% | 0.00% | +100.0% |
Q3 2019 | $24,000 | -53.8% | 4,398 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $52,000 | +126.1% | 4,398 | 0.0% | 0.00% | +100.0% |
Q1 2019 | $23,000 | +64.3% | 4,398 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $14,000 | -48.1% | 4,398 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $27,000 | +17.4% | 4,398 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $23,000 | +475.0% | 4,398 | +191.5% | 0.00% | – |
Q1 2017 | $4,000 | – | 1,509 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |